HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Human Molecular Genetics

• Publication date

  2015-03-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddv080PMID 25740845PMCID PMC4424959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides.

  2014cited by this paper
• Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients

  2014cited by this paper
• Neurogenesis in the striatum of the adult human brain.

  2014cited by this paper
• Advances in Huntington Disease Drug Discovery

  2014cited by this paper
• Assessment of human pluripotent stem cells with PluriTest

  2014cited by this paper
• Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease

  2013cited by this paper
• Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease.

  2013cited by this paper
• EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs.

  2013cited by this paper
• A Small Molecule TrkB Ligand Reduces Motor Impairment and Neuropathology in R6/2 and BACHD Mouse Models of Huntington's Disease

  2013cited by this paper
• BDNF prevents NMDA‐induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved

  2013cited by this paper
• Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS

  2013cited by this paper
• The incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis

  2012cited by this paper
• P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.

  2012cited by this paper
• Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.

  2012cited by this paper
• BDNF control of adult SVZ neurogenesis.

  2012cited by this paper
• Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.

  2012cited by this paper
• Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation.

  2012cited by this paper
• Inhibition of Apoptosis Blocks Human Motor Neuron Cell Death in a Stem Cell Model of Spinal Muscular Atrophy

  2012cited by this paper
• A call for standardized naming and reporting of human ESC and iPSC lines.

  2011cited by this paper
• A bioinformatic assay for pluripotency in human cells

  2011cited by this paper
• Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin.

  2011cited by this paper
• A more efficient method to generate integration-free human iPS cells

  2011cited by this paper
• Identification of cis-Elements and Transcription Factors Regulating Neuronal Activity-Dependent Transcription of Human BDNF Gene

  2011cited by this paper
• Huntington’s Disease and Group I Metabotropic Glutamate Receptors

  2011cited by this paper
• Induced pluripotent stem cells: a new revolution for clinical neurology?

  2011cited by this paper
• Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease.

  2011cited by this paper
• Neuregulin1/ErbB4-induced migration in ST14A striatal progenitors: calcium-dependent mechanisms and modulation by NMDA receptor activation

  2011cited by this paper
• BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice

  2010cited by this paper
• Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells

  2010cited by this paper
• Stem Cell Quiescence in the Hippocampal Neurogenic Niche Is Associated With Elevated Transforming Growth Factor-&bgr; Signaling in an Animal Model of Huntington Disease

  2010cited by this paper
• Brain-derived neurotrophic factor in neurodegenerative diseases

  2009cited by this paper
• Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

  2009cited by this paper
• Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease

  2009cited by this paper
• Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin

  2009cited by this paper
• Aging and Replicative Senescence Have Related Effects on Human Stem and Progenitor Cells

  2009cited by this paper
• Isolating, expanding, and infecting human and rodent fetal neural progenitor cells.

  2008cited by this paper
• Variant Brain-Derived Neurotrophic Factor (Val66Met) Alters Adult Olfactory Bulb Neurogenesis and Spontaneous Olfactory Discrimination

  2008cited by this paper
• Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice

  2008cited by this paper
• Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.

  2008cited by this paper
• Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats

  2008cited by this paper
• Excitotoxic neuronal death and the pathogenesis of Huntington's disease.

  2008cited by this paper
• Deletion of TrkB in adult progenitors alters newborn neuron integration into hippocampal circuits and increases anxiety-like behavior

  2008cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Group I mGluR5 metabotropic glutamate receptors regulate proliferation of neuronal progenitors in specific forebrain developmental domains

  2007cited by this paper
• AAV‐mediated delivery of BDNF augments neurogenesis in the normal and quinolinic acid‐lesioned adult rat brain

  2007cited by this paper
• Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease.

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Nestin immunoreactivity of Purkinje cells in Creutzfeldt-Jakob disease.

  2006cited by this paper
• Glutamate enhances proliferation and neurogenesis in human neural progenitor cell cultures derived from the fetal cortex

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Glutamate as a modulator of embryonic and adult neurogenesis.

  2006cited by this paper
• Brain-Derived Neurotrophic Factor and Antidepressant Drugs Have Different But Coordinated Effects on Neuronal Turnover, Proliferation, and Survival in the Adult Dentate Gyrus

  2005cited by this paper
• Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.

  2005cited by this paper
• Abnormalities of Neurogenesis in the R6/2 Mouse Model of Huntington's Disease Are Attributable to the In Vivo Microenvironment

  2005cited by this paper
• Activation of Neuroprotective Pathways by Metabotropic Group I Glutamate Receptors: A Potential Target for Drug Discovery?

  2005cited by this paper
• Inhibition of Metabotropic Glutamate Receptor Signaling by the Huntingtin-binding Protein Optineurin*

  2005cited by this paper
• Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats.

  2005cited by this paper
• Group I metabotropic glutamate receptors reduce excitotoxic injury and may facilitate neurogenesis.

  2005cited by this paper
• Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategies.

  2005cited by this paper
• Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine

  2005cited by this paper
• Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's Disease

  2004cited by this paper
• The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease.

  2004cited by this paper
• Generalized brain and skin proteasome inhibition in Huntington's disease

  2004cited by this paper
• Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease.

  2004cited by this paper
• Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease.

  2004cited by this paper
• Glutamate Promotes Proliferation of Striatal Neuronal Progenitors by an NMDA Receptor-Mediated Mechanism

  2003cited by this paper
• Huntingtin and Huntingtin-Associated Protein 1 Influence Neuronal Calcium Signaling Mediated by Inositol-( 1 , 4 , 5 ) Triphosphate

  2003cited by this paper
• Aberrant A2A receptor function in peripheral blood cells in Huntington's disease

  2003cited by this paper
• Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1.

  2003cited by this paper
• Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain

  2003cited by this paper
• Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.

  2002cited by this paper
• Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses.

  2002cited by this paper
• Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses.

  2002cited by this paper
• NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity.

  2001cited by this paper
• Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective Drugs

  2001cited by this paper
• Polyglutamine-expanded Huntingtin Promotes Sensitization of N-Methyl-d-aspartate Receptors via Post-synaptic Density 95*

  2001cited by this paper
• Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease

  2001cited by this paper
• Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.

  2000cited by this paper
• Brain-derived neurotrophic factor in Huntington disease.

  2000cited by this paper
• Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.

  1999cited by this paper
• Expression of nestin after traumatic brain injury in rat brain.

  1999cited by this paper
• Subtype‐Specific Enhancement of NMDA Receptor Currents by Mutant Huntingtin

  1999cited by this paper
• Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain.

  1998cited by this paper
• NMDA receptor antagonists influence early development of GABAergic interneurons in the mammalian striatum.

  1998cited by this paper
• NMDA receptor antagonists influence early development of GABAergic interneurons in the mammalian striatum

  1998cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• Homologous recombination based modification in Esherichia coli and germline transmission in transgenic mice of a bacterial artificial chromsome

  1997cited by this paper
• Changes of NMDA Receptor Subunit (NR1, NR2B) and Glutamate Transporter (GLT1) mRNA Expression in Huntington's Disease—An In Situ Hybridization Study

  1997cited by this paper
• Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

  1996cited by this paper
• GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis.

  1995cited by this paper
• Trinucleotide repeat length instability and age of onset in Huntington's disease

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

  1993cited by this paper
• Excitotoxic injury of the neostriatum: a model for Huntington's disease.

  1990cited by this paper
• [3H]MK-801 binding sites in post-mortem human frontal cortex.

  1989cited by this paper
• DNA Synthesis and Cell Division in the Adult Primate Brain a

  1985cited by this paper
• Pluripotent embryonic stem cell lines can be derived from tw5/tw5 blastocysts

  1982cited by this paper
• Huntington's disease: Changes in striatal proteins reflect astrocytic gliosis

  1982cited by this paper
• Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat.

  1977cited by this paper

• Roles of MAPKs, Including Those Activated by BDNF/TrkB, and Their Contribution in Neurodegenerative Diseases

  2026cites this paper
• Mutant huntingtin exon 1 protein detected in mouse brain with neoepitope antibody: effects of CAG repeat expansion, MutS Homolog 3 silencing and aggregation

  2025cites this paper
• Brain organoid models of Huntington's disease shift the focus towards neurodevelopment

  2025cites this paper
• Durable HTT silencing using non-evolved dCas9 epigenome editors in patient-derived cells

  2025cites this paper
• Stage-Specific Serum Proteomic Signatures Reveal Early Biomarkers and Molecular Pathways in Huntington’s Disease Progression

  2025cites this paper
• Neuron-derived extracellular vesicles in plasma present a potential non-invasive biomarker for Huntingtin protein and RNA assessment in Huntington disease

  2025cites this paper
• The Huntington's disease drug pipeline: a review of small molecules and their therapeutic targets.

  2025cites this paper
• Current Development of iPSC-Based Modeling in Neurodegenerative Diseases

  2025cites this paper
• Intersecting impact of CAG repeat and huntingtin knockout in stem cell-derived cortical neurons

  2025cites this paper
• Intersecting impact of CAG repeat and Huntingtin knockout in stem cell-derived cortical neurons

  2025cites this paper
• Rapid and high-purity differentiation of human medium spiny neurons reveals LMNB1 hypofunction and subtype necessity in modeling Huntington’s disease

  2024cites this paper
• Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies

  2024cites this paper
• How to differentiate induced pluripotent stem cells into sensory neurons for disease modelling: a functional assessment

  2024cites this paper
• Mutant huntingtin confers cell-autonomous phenotypes on Huntington’s disease iPSC-derived microglia

  2023cites this paper
• Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2

  2023cites this paper
• Brain-Derived Neurotrophic Factor Dysregulation as an Essential Pathological Feature in Huntington’s Disease: Mechanisms and Potential Therapeutics

  2023cites this paper
• Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease

  2023cites this paper
• Tetracycline‐Inducible and Reversible Stable Gene Expression in Human iPSC‐Derived Neural Progenitors and in the Postnatal Mouse Brain

  2023cites this paper
• The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review

  2023influential citation
• Extracellular vesicles improve GABAergic transmission in Huntington's disease iPSC-derived neurons

  2023influential citation
• Haplotype-specific insertion-deletion variations for allele-specific targeting in Huntington's disease

  2022cites this paper
• Retinoic acid receptor beta protects striatopallidal medium spiny neurons from mitochondrial dysfunction and neurodegeneration.

  2022cites this paper
• Single-nuclei transcriptome analysis of Huntington disease iPSC and mouse astrocytes implicates maturation and functional deficits

  2022cites this paper
• Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington’s disease models

  2022cites this paper
• Deep-learning analysis of micropattern-based organoids enables high-throughput drug screening of Huntington’s disease models

  2022cites this paper
• Vesicular Glutamate Release from Feeder-FreehiPSC-Derived Neurons

  2022cites this paper
• Allele-specific silencing of the gain-of-function mutation in Huntington’s disease using CRISPR/Cas9

  2022cites this paper
• PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington’s disease

  2022cites this paper
• An insight into the iPSCs-derived two-dimensional culture and three-dimensional organoid models for neurodegenerative disorders

  2022cites this paper
• Integrated transcriptome analysis of Huntington’s disease iPSC-derived and mouse astrocytes implicates dysregulated synaptogenesis, actin, and astrocyte maturation

  2022cites this paper
• Skeletal Muscle Pathogenesis in Polyglutamine Diseases

  2022cites this paper
• The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders

  2022cites this paper
• Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in vivo in CNS

  2022cites this paper
• Huntington’s disease iPSC models—using human patient cells to understand the pathology caused by expanded CAG repeats

  2022cites this paper
• Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset

  2022cites this paper
• Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic

  2022cites this paper
• Human Huntington’s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species

  2021cites this paper
• Novel epigenetic clock for fetal brain development predicts prenatal age for cellular stem cell models and derived neurons

  2021cites this paper
• Perinatal exposure to a glyphosate-based herbicide causes dysregulation of dynorphins and an increase of neural precursor cells in the brain of adult male rats.

  2021cites this paper
• Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics.

  2021cites this paper
• Cell Reprogramming to Model Huntington’s Disease: A Comprehensive Review

  2021influential citation
• Theranostics

  2021cites this paper
• Cell-Based Delivery Approaches for DNA-Binding Domains to the Central Nervous System

  2021cites this paper
• Directly reprogrammed Huntington's disease neural precursor cells generate striatal neurons exhibiting aggregates and impaired neuronal maturation

  2021cites this paper
• Gene therapy to the blood–brain barrier with resulting protein secretion as a strategy for treatment of Niemann Picks type C2 disease

  2020cites this paper
• The Interaction of Aging and Cellular Stress Contributes to Pathogenesis in Mouse and Human Huntington Disease Neurons

  2020cites this paper
• In vivo progressive degeneration of Huntington’s disease patient-derived neurons reveals human-specific pathological phenotypes

  2020cites this paper
• Novel epigenetic clock for fetal brain development predicts fetal epigenetic age for iPSCs and iPSC-derived neurons

  2020cites this paper
• Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

  2020cites this paper
• Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting

  2020cites this paper
• DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis.

  2020cites this paper
• Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation

  2020cites this paper
• Pueraria lobata and Daidzein Reduce Cytotoxicity by Enhancing Ubiquitin-Proteasome System Function in SCA3-iPSC-Derived Neurons

  2019cites this paper
• Induced pluripotent stem cells for neural drug discovery.

  2019cites this paper
• Modeling spinocerebellar ataxias 2 and 3 with iPSCs reveals a role for glutamate in disease pathology

  2019cites this paper
• Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease

  2019cites this paper
• Bioenergetic deficits in Huntington’s disease iPSC-derived neural cells and rescue with glycolytic metabolites

  2019cites this paper
• Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

  2019cites this paper
• Neural tissue microphysiological systems in the era of patient-derived pluripotent stem cells

  2019cites this paper
• Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington's disease.

  2019cites this paper
• Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor.

  2019cites this paper
• Huntington’s Disease Patient-Derived Astrocytes Display Electrophysiological Impairments and Reduced Neuronal Support

  2019cites this paper
• Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease

  2019cites this paper
• Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations

  2019cites this paper
• Characterization of Neurodevelopmental Abnormalities in iPSC-Derived Striatal Cultures from Patients with Huntington’s Disease

  2019cites this paper
• Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington’s Disease: Insights from In Vitro and In Vivo Models

  2019cites this paper
• Back to the origins: human brain organoids to investigate neurodegeneration.

  2019cites this paper
• The interaction of aging and oxidative stress contributes to pathogenesis in mouse and human Huntington disease neurons

  2019influential citation
• Expanded huntingtin CAG repeats disrupt the balance between neural progenitor expansion and differentiation in human cerebral organoids

  2019cites this paper
• Cysteamine Protects Neurons from Mutant Huntingtin Toxicity

  2019cites this paper
• The GluN2B subunit represents a major functional determinant of NMDA receptors in human induced pluripotent stem cell-derived cortical neurons.

  2018cites this paper
• Blockade of the swelling-induced chloride current attenuates the mouse neonatal hypoxic-ischemic brain injury in vivo

  2018cites this paper
• Integrating Omics data : a new software tool and its use in implicating therapeutic targets in Huntington's disease

  2018cites this paper
• Human iPSC-Derived Endothelial Cells and Microengineered Organ-Chip Enhance Neuronal Development

  2018cites this paper
• Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes

  2018cites this paper
• FAN1 modifies Huntington’s disease progression by stabilising the expanded HTT CAG repeat

  2018cites this paper
• Human Huntington's Disease iPSC-Derived Cortical Neurons Display Altered Transcriptomics, Morphology, and Maturation.

  2018cites this paper
• FAN1 modifies Huntington’s disease progression by stabilizing the expanded HTT CAG repeat

  2018cites this paper
• Neural Stem Cell Dysfunction in Human Brain Disorders.

  2018cites this paper
• Human cellular models of medium spiny neuron development and Huntington disease

  2018cites this paper
• Cellular Models: HD Patient-Derived Pluripotent Stem Cells.

  2018cites this paper
• Stem Cell-Based Therapies for Polyglutamine Diseases.

  2018cites this paper
• Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease

  2018cites this paper
• Modeling Psychomotor Retardation using iPSCs from MCT8-Deficient Patients Indicates a Prominent Role for the Blood-Brain Barrier.

  2017cites this paper
• Huntington ’ s Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits Graphical

  2017cites this paper
• Pluripotent Stem Cells to Model and Treat Huntington’s Disease

  2017cites this paper
• Title Phosphorylation of huntingtin at residue T 3 is decreased in Huntington ' s disease and modulates mutant huntingtin protein conformation Permalink

  2017cites this paper
• Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model

  2017influential citation
• Optimization of trans-Splicing for Huntington's Disease RNA Therapy

  2017influential citation
• Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation

  2017cites this paper
• Modeling Huntington׳s disease with patient-derived neurons.

  2017influential citation
• Survival of iPSC-derived grafts within the striatum of immunodeficient mice: Importance of developmental stage of both transplant and host recipient.

  2017cites this paper
• Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice

  2017cites this paper
• FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington’s disease and their derived neural cells

  2017cites this paper
• Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells

  2017influential citation
• Tetracycline-Inducible and Reversible Stable Gene Expression in Human iPSC-Derived Neural Progenitors and in the Postnatal Mouse Brain.

  2017cites this paper
• Huntington’s Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits

  2017cites this paper
• Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders

  2016cites this paper
• Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.

  2016cites this paper
• Use of human stem cells in Huntington disease modeling and translational research.

  2016cites this paper